Wells Fargo’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Wells Fargo’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-50	Closed	-$4K	–	6845
2018 Q1	$4K	Hold	50	–	–	﹤0.01%	6125
2017 Q4	$4K	Hold	50	–	–	﹤0.01%	6117
2017 Q3	$5K	Sell	50 -63	-56%	-$6.05K	﹤0.01%	6048
2017 Q2	$13K	Buy	113 +12	+12%	+$1.34K	﹤0.01%	5729
2017 Q1	$10K	Buy	101 +15	+17%	+$1.6K	﹤0.01%	5892
2016 Q4	$9K	Sell	86 -30	-26%	-$3.51K	﹤0.01%	5845
2016 Q3	$14K	Sell	116 -100	-46%	-$11.8K	﹤0.01%	5702
2016 Q2	$23K	Buy	216 +70	+48%	+$8.13K	﹤0.01%	5461
2016 Q1	$17K	Sell	146 -25	-15%	-$2.93K	﹤0.01%	5560
2015 Q4	$24K	Buy	171 +32	+23%	+$3.69K	﹤0.01%	5535
2015 Q3	$12K	Sell	139 -7,859	-98%	-$830K	﹤0.01%	5695
2015 Q2	$921K	Buy	7,998 +891	+13%	+$93.6K	﹤0.01%	3677
2015 Q1	$679K	Buy	7,107 +5,055	+246%	+$378K	﹤0.01%	3766
2014 Q4	$138K	Hold	2,052	–	–	﹤0.01%	4607
2014 Q3	$111K	Buy	2,052 +1,202	+141%	+$59.2K	﹤0.01%	4614
2014 Q2	$38K	Buy	+850	New	+$34.7K	﹤0.01%	5083

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo's CBPO Position: Q2 2018 in Review

Wells Fargo sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2018, closing a stake of 50 shares — an estimated $4K sold.

Wells Fargo first reported a position in CBPO in Q2 2014 and held it in 16 quarters. The position peaked at $921K in Q2 2015. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2018.

Wells Fargo reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2018 after selling out during the quarter.
Wells Fargo sold 50 China Biologic Products Holdings, Inc. shares in Q2 2018, an estimated $4K.
Wells Fargo first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 16 quarters.
Wells Fargo's China Biologic Products Holdings, Inc. position peaked at $921K in Q2 2015.
91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2018.

Based on Wells Fargo's 13F filing for Q2 2018, filed 1 Aug 2018.